Filed: 8/13/2025ACC: 0001964437-25-000008
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 24 equity positions with a total reported market value of $246.76M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
24
Positions
$246.76M
Total AUM (reported)
14.78M
Total Shares
Allocation by class
COM$178.16M72.2%
SHS USD$21.96M8.9%
SPONSORED ADS$15.19M6.2%
CLASS A ORD$13.73M5.6%
SPONSORED ADR$12.26M5.0%
ORDINARY SHARES$4.00M1.6%
CL A$1.27M0.5%
Portfolio Concentration
Top 3$63.84M25.9%
4–10$107.51M43.6%
11–25$75.41M30.6%
Top 3 weight
25.9%
Top 10 weight
69.4%
Voting Authority Distribution
Total shares with voting rights: 14.78M
Sole
Full voting authority
14.78M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole24
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings24
Rows:
JAZZ PHARMACEUTICALS PLC
SOLEShares206.95K
TypeSH
Market value$21.96M
8.90%
Sole
206.95K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares396.12K
TypeSH
Market value$20.98M
8.50%
Sole
396.12K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares3.26M
TypeSH
Market value$20.90M
8.47%
Sole
3.26M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares544.22K
TypeSH
Market value$17.69M
7.17%
Sole
544.22K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares2.30M
TypeSH
Market value$16.50M
6.69%
Sole
2.30M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares1.19M
TypeSH
Market value$15.83M
6.41%
Sole
1.19M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares586.65K
TypeSH
Market value$15.25M
6.18%
Sole
586.65K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares468.36K
TypeSH
Market value$14.66M
5.94%
Sole
468.36K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares1.46M
TypeSH
Market value$13.86M
5.62%
Sole
1.46M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares290.78K
TypeSH
Market value$13.73M
5.56%
Sole
290.78K
Shared
0.00
None
0.00
MERUS N V
SOLEShares224.26K
TypeSH
Market value$11.80M
4.78%
Sole
224.26K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares793.33K
TypeSH
Market value$10.42M
4.22%
Sole
793.33K
Shared
0.00
None
0.00
LENZ THERAPEUTICS INC
SOLEShares342.31K
TypeSH
Market value$10.03M
4.07%
Sole
342.31K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares58.18K
TypeSH
Market value$7.31M
2.96%
Sole
58.18K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares728.58K
TypeSH
Market value$6.76M
2.74%
Sole
728.58K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares38.19K
TypeSH
Market value$6.59M
2.67%
Sole
38.19K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares10.29K
TypeSH
Market value$5.67M
2.30%
Sole
10.29K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares622.48K
TypeSH
Market value$4.76M
1.93%
Sole
622.48K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares500.55K
TypeSH
Market value$4.69M
1.90%
Sole
500.55K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares220.69K
TypeSH
Market value$4.00M
1.62%
Sole
220.69K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares319.35K
TypeSH
Market value$1.27M
0.51%
Sole
319.35K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares128.92K
TypeSH
Market value$1.20M
0.49%
Sole
128.92K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares62.79K
TypeSH
Market value$709.9K
0.29%
Sole
62.79K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares34.74K
TypeSH
Market value$201.5K
0.08%
Sole
34.74K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 206.95K | SH | $21.96M 8.90% | 206.95K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 396.12K | SH | $20.98M 8.50% | 396.12K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 3.26M | SH | $20.90M 8.47% | 3.26M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 544.22K | SH | $17.69M 7.17% | 544.22K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 2.30M | SH | $16.50M 6.69% | 2.30M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 1.19M | SH | $15.83M 6.41% | 1.19M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 586.65K | SH | $15.25M 6.18% | 586.65K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 468.36K | SH | $14.66M 5.94% | 468.36K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 1.46M | SH | $13.86M 5.62% | 1.46M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 290.78K | SH | $13.73M 5.56% | 290.78K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 224.26K | SH | $11.80M 4.78% | 224.26K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 793.33K | SH | $10.42M 4.22% | 793.33K | 0.00 | 0.00 |
LENZ THERAPEUTICS INCSOLE | COM | 342.31K | SH | $10.03M 4.07% | 342.31K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 58.18K | SH | $7.31M 2.96% | 58.18K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 728.58K | SH | $6.76M 2.74% | 728.58K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 38.19K | SH | $6.59M 2.67% | 38.19K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 10.29K | SH | $5.67M 2.30% | 10.29K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 622.48K | SH | $4.76M 1.93% | 622.48K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 500.55K | SH | $4.69M 1.90% | 500.55K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 220.69K | SH | $4.00M 1.62% | 220.69K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 319.35K | SH | $1.27M 0.51% | 319.35K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 128.92K | SH | $1.20M 0.49% | 128.92K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 62.79K | SH | $709.9K 0.29% | 62.79K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 34.74K | SH | $201.5K 0.08% | 34.74K | 0.00 | 0.00 |